Echotherapy Market To Supersede Linear Transition

New York, United States, 2022-Apr-14 — /EPR Network/ —

The global Echotherapy Market is there to grow at a noteworthy In Upcoming Years. These days, pre-empt process breakdowns by making use of AI are the ongoing trend. Regulatory compliance is also being adhered to using data masking. Personalized smart videos are being used to render proper member communication. These, and many such digitally transformative approaches are being followed in the enterprise as of now and the scenario is expected to remain the same even going forward.

Echotherapy is a new considerate treatment for non-cancerous thyroid nodules, varicose veins, and fibroadenoma of the breast. Echotherapy works with the therapeutic ultrasound, also known as high-intensity focused ultrasound (HIFU). Echotherapy is completely non-invasive and doesn’t leave any scars, compared to other treatment methods such as radiofrequency ablation or laser treatment or surgery.

Echotherapy for varicose veins is the most recent medical advancement in expert options. It is the only method which is 100% non-invasive and not performed in an operation theatre. It is the only technique which treats from outside the body and therefore leaves no scar and allows the patient to resume normal activity immediately. Therapeutic ultrasound waves is used in echotherapy like the ones used during an ultrasound exam.

Nowadays, prostate cancer are mostly treated by echotherapy using high frequency ultrasound energy. Echotherapy is widely used in the field of interventional oncology owing to its favorable treatment margins, non-invasiveness, and low complication rates. Echotherapy offers several benefits over traditional ultrasound systems such as less bleeding and low procedural time.

Get Sample Copy of this Report@

Furthermore, the surgical procedures using these devices are typically minimally invasive, cost effective, and less painful. The demand for echotherapy is likely to grow with the increasing demand for minimally invasive therapy and rising technological advancements.

The global echotherapy market is primarily driven by the rising prevalence of cancer across the globe, increasing public-private investments, and growing demand for minimally invasive treatment procedures. Furthermore, the growing advancements in medical technology and its wide-range applications used in the treatment of neurological disorders, and uterine fibroids have propelled the growth of the global echotherapy market.

Emerging applications such as neurosurgery, urinary disease imaging, gynecology & obstetrics, and removal or reduction of excess subcutaneous fatty tissue from the body using high-frequency sound waves would further propel the growth of the global echotherapy market during the forecast period.

However, unfavorable reimbursement scenario, stringent regulations for the approval of new technologies, and rising price pressure are the key factors restraining the growth of echotherapy market. Furthermore, lack of professionals to handle advanced technologies in some regions especially, in developing countries are also likely to hamper the growth of the global echotherapy market.

Request for Table of Content@

Based on application, the global echotherapy market has been segmented as,

  • Neurological Disorders
  • Prostate Cancer
  • Uterine Fibroids
  • Others

Based on end user, the global echotherapy market has been segmented as,

  • Hospitals
  • Diagnostic Centers
  • Research Centers

Based on region, the global echotherapy market has been segmented as,

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Access Full Report@

Competitive Landscape

  • Image-Guided Therapy
  • Theraclion
  • SonaCare Medical
  • LLC
  • Chongqing Haifu Medical Technology Co. Ltd
  • Shanghai A&S Co. LTD
  • Koninklijke Philips N.V.
  • FUS Instruments
  • Insightec
  • Alpinion Medical Systems
  • others

About us: Persistence Market Research

Contact us:

Persistence Market Research          
Address – 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales –

Matched content

Editor’s pick

Express Press Release Distribution